Nanotechnology Now

Our NanoNews Digest Sponsors

Heifer International

Wikipedia Affiliate Button

Home > Press > CEA initiates the first French nanobiotech cluster in Grenoble

CEA initiates the first French nanobiotech cluster in Grenoble

Grenoble, France | September 27, 2005

CEA (French Atomic Energy Commission) the major European Technological Research Organisation, announces the creation of the first French nanobiotechnology cluster. The official launch was made on September 9th with the signature of a real estate operation dedicated to host new equipments and research teams in Grenoble close to the Minatec facilities.

The new cluster, called NanoBio, gathers three research partners: University Joseph Fourier, Hospital of La Tronche and CEA. A first phase is going to be funded by local authorities (Metropolitan Area of Grenoble, Rhone-Alpes Region, Isere Department and City of Grenoble) for a total amount of 23,5 M€. NanoBio will bring together engineers, physicists, chemists, biologists and medical doctors to develop new miniaturised tools for biological and medicine applications: biochips, lab-on-chips, biosensors… These tools will be used for medical diagnosis, food safety control, environmental monitoring, etc.

The aim of NanoBio is to foster the technological and economical development in the bioengineering field, taking advantage of the CEA’s 10-years experience in biochips and bioMEMS research. NanoBio is created in synergy with Minatec, the 1st European innovation Centre for micro and nanotechnology. It will also work in deep connection with Lyon Biopole, a major biotech cluster dedicated to diagnosis and vaccines.

Instigator of both Minatec and NanoBio projects, the CEA is internationally acknowledged for its research in micro and nanotechnologies for life sciences. LETI (Laboratory of Electronics and Information Technologies) has dedicated a full department (120 persons) to micro and nanotechnologies for biology and healthcare, and conducts research projects aimed at technology transfer.

Since 2004, the CEA leads the Nano2Life European network of excellence, gathering 23 partners in 12 countries and more than 200 scientists. Supported by the European Commission, Nano2Life is intended to establish the first steps towards an European Institute of Nanobiotechnology.

####

About CEA Leti:
The CEA plays a major role in research, development and innovation in three main fields: energy, information and healthcare technologies, and defence. Set up on 9 centres located all over France, the CEA benefits from a strong regional insertion and solid partnerships with other research organisations, local authorities and universities.

A laboratory of the CEA in Grenoble, the Laboratory of electronics and information technologies (Leti) is at the leading edge of European research on microelectronics and micro-nanotechnologies. It employs more than 900 people. With its 110 patents filed per year and its twenty-eight start-ups created or in the course of creation, it is one of the major partners of the industrial world.

For more information, please visit www.cea.fr/gb/index.asp

Media Contacts:
Cappe de Baillon
patrick.cappedebaillon@cea.fr

Copyright © CEA Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

Investments/IPO's/Splits

180 Degree Capital Corp. Announces the Start of Kevin Rendino as Chairman and Chief Executive Officer and Completion of its Transition to a Registered Closed-End Fund March 31st, 2017

Harris & Harris Group Issues Its Financial Statements as of December 31, 2016, Posts Its Annual Shareholder Letter, And Will Host a Conference Call for Shareholders on Friday, March 17, 2017 March 15th, 2017

Harris & Harris Group Announces the Filing of Preliminary Proxy Materials Detailing Its Proposed Conversion From a BDC to a Registered Closed-End Fund January 24th, 2017

Harris & Harris Group Issues Reminder for Shareholder Update Call on January 10, 2017 January 10th, 2017

Nanomedicine

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

Nanoparticle vaccine shows potential as immunotherapy to fight multiple cancer types April 24th, 2017

Arrowhead Presents ARC-520 and ARC-521 Clinical Data at The International Liver Congress(TM) April 20th, 2017

Announcements

Metal nanoparticles induced visible-light photocatalysis: Mechanisms, applications, ways of promoting catalytic activity and outlook April 27th, 2017

Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results April 27th, 2017

New Product Nanoparticle preparation from Intertronics with new Thinky NP-100 Nano Pulveriser April 26th, 2017

California Research Alliance by BASF establishes more than 25 research projects in three years April 26th, 2017

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project